TransMedics Group, Inc. - TMDX

SEC FilingsOur TMDX Tweets

About Gravity Analytica

Recent News

  • 09.16.2025 - Daniel Markowitz
  • 09.09.2025 - Baird 2025 Global Healthcare Conference
  • 09.08.2025 - Thomas Stephan
  • 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
  • 08.25.2025 - TransMedics to Present at Upcoming September Investor Conferences
  • 08.12.2025 - Canaccord Genuity 45th Annual Growth Conference
  • 08.04.2025 - TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial
  • 08.01.2025 - TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • 07.30.2025 - TransMedics Q2 2025 Earnings Conference Call
  • 07.30.2025 - TransMedics Q2 2025 Earnings Conference Call

Recent Filings

  • 08.08.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.05.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.04.2025 - 144 Report of proposed sale of securities
  • 07.30.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 07.30.2025 - 8-K Current report
  • 07.30.2025 - EX-99.1 EX-99.1
  • 07.18.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors